Daratumumab,Talquetamab,Teclistamab,Pomalidomide
janssen,genmab
['4108', 'trimm-2', 'mmsm', '1081', 'multiplemyeloma', 'ct041']
nct04108195: phase 1b - subcutaneous dara with bispecific t cell redirection antibodies - trimm-2
#mmsm #multiplemyeloma #eha2022 
Multiple Myeloma Education Platform for Myeloma Community